Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-11-000002
Filing Date
2011-03-31
Accepted
2011-03-31 16:03:02
Documents
6
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K a10k_123110.htm 10-K 1223484
2 SUBSIDIARIES ex_21.htm EX-21 3904
3 AUDITORS CONSENT ex_23-1.htm EX-23.1 3623
4 CEO CERTIFICATION ex_31-1.htm EX-31.1 21151
5 CFO CERTIFICATION ex_31-2.htm EX-31.2 21298
6 CEO/CFO CERTIFICATION ex_32.htm EX-32 8287
  Complete submission text file 0000318306-11-000002.txt   1282954
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 11726182
SIC: 2834 Pharmaceutical Preparations